Tempus AI Inc. (NASDAQ:TEM) is one of the top 10 hidden AI stocks to buy. On May 31, Tempus AI launched the next generation of Lens, an agentic AI platform designed to accelerate oncology drug development. By integrating Tempus’ massive library of longitudinal real-world data, oncology foundation models, and computational infrastructure, the platform provides an […]
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
529last 24h
2502last 7d
477● bullish (7d)
254● bearish (7d)
197publishers
Insider Monkey30d agoneutral
Tempus AI (TEM) Launches Next-Gen Agentic Platform to Accelerate Oncology ResearchInsider Monkey73d agoneutral
Tempus AI (TEM) Launches ArteraAI Prostate Test, The First Externally Developed Digital Pathology AlgorithmTrading with an implied upside of 60.5% and an RSI of 34.6, Tempus AI, Inc. (NASDAQ:TEM) has emerged as a notable oversold play in the AI sector. In a span of a week, Tempus AI, Inc. (NASDAQ:TEM) made two announcements that add to its growing pipeline of clinical and pharma partnerships. The freshest update came […]